WOLFF STEFANI (Senior VP of Strategy and Ops) sold 13.4% of their position (5.50K shares) of PRINCIPIA BIOPHARMA INC. on the open market
Open‑market sale worth $254.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/18/2020ACC: 0001209191-20-020043
Officer· Senior VP of Strategy and Ops
Since Sep 2018
-5.50K
Net shares
Net seller
$254.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
5.50K acquired · 11.01K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+5.50K
Price / share
$4.54
Trade value
$25K
% of position
15.5%
3/16/2020
35.61K→41.11K
Common Stock
Direct
Shares
−1.75K
Price / share
$45.72
Trade value
$80.19K
% of position
4.3%
3/16/2020
41.11K→39.36K
Common Stock
Direct
Shares
−3.75K
Price / share
$46.36
Trade value
$173.84K
% of position
9.5%
3/16/2020
39.36K→35.61K
Total
Net shares
+0.00
Net value
-$229.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2020 | M · Option Exercise | +5.50K | $4.54 | $25K | 15.5% | 35.61K | 41.11K |
| Common Stock Direct | 3/16/2020 | S · Sale | −1.75K | $45.72 | $80.19K | 4.3% | 41.11K | 39.36K |
| Common Stock Direct | 3/16/2020 | S · Sale | −3.75K | $46.36 | $173.84K | 9.5% | 39.36K | 35.61K |
| Total | +0.00 | -$229.03K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
4.542
Held after
19.05K
Exercisable
—
3/16/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5.50K shares | 3/16/2020 | M · Option Exercise | −5.50K | 4.542 | — | 19.05K |